Neutrophils in atherosclerosis: A brief overview

Hamostaseologie

Volumn 35, Issue 2, 2015, Pages 121-127

  Hartwig, Helene ^a   Silvestre Roig, C ^a   Daemen, M ^a   Lutgens, E ^a,b   Soehnlein, O ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atherosclerosis; Inflammation; Neutrophils

Indexed keywords

PROTEINASE; AUTACOID; CYTOKINE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MORTALITY; CHRONIC INFLAMMATION; DISEASE COURSE; HUMAN; HYPERLIPIDEMIA; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MONOCYTE; MORTALITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NEUTROPHILIA; NONHUMAN; REVIEW; ANIMAL; BIOLOGICAL MODEL; CLASSIFICATION; IMMUNOLOGY; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MODELS, CARDIOVASCULAR; MODELS, IMMUNOLOGICAL; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 84939153727     PISSN: 07209355     EISSN: 25675761     Source Type: Journal    
DOI: 10.5482/hamo-14-09-0040     Document Type: Review

References (70)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473:317-325.
2. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17:1410-1422.
3. Drechsler M, Megens RTA, van Zandvoort M et al. Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis. Circulation 2010; 122:1837-1845.
4. Ionita MG, van den Borne P, Catanzariti LM et al. High Neutrophil Numbers in Human Carotid Atherosclerotic Plaques Are Associated With Characteristics of Rupture-Prone Lesions. Arteriosclerosis, Thromb Vasc Biol 2010; 30:1842-1848.
5. Moreno JA, Ortega-Gomez A, Delbosc S et al. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J 2012; 33:252-263.
6. Hartaigh B, Bosch JA, Thomas GN et al. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis 2012; 224:161-169.
7. Semerad CL, Liu F, Gregory AD et al. G-CSF Is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 2002; 17:413-423.
8. Martin C, Burdon PCE, Bridger G et al. Chemokines Acting via CXCR2 and CXCR4 Control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003; 19:583-593.
9. Strydom N, Rankin SM. Regulation of circulating neutrophil numbers under homeostasis and in disease. J Innate Immunity 2013; 5:304-314.
10. Zernecke A, Bot I, Djalali-Talab Y et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circulation Res 2008; 102:209-217.
11. Bot I, Daissormont IT, Zernecke A et al. CXCR4 blockade induces atherosclerosis by affecting neutrophil function. J Mol Cell Cardiol 2014; 74:44-52.
12. Casanova-Acebes Ma, Pitaval C, Weiss L et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 2013; 153:1025-1035.
13. Swirski FK, Nahrendorf M, Etzrodt M et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325:612-616.
14. Yvan-Charvet L, Pagler T, Gautier EL et al. ATPbinding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010; 328:1689-1693.
15. Westerterp M, Gourion-Arsiquaud S, Murphy A et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012; 11:195-206.
16. Murphy AJ, Akhtari M, Tolani S et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 2011; 121:4138-4149.
17. Nagareddy P, Murphy A, Stirzaker R et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metabolism 2013; 17:695-708.
18. Nagareddy P, Kraakman M, Masters S et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metabolism 2014; 19:821-835.
19. Heidt T, Sager HB, Courties G et al. Chronic variable stress activates hematopoietic stem cells. Nat Med 2014; 20:754-758.
20. Döring Y, Soehnlein O, Drechsler M et al. Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mnice. Arterioscler Thromb Vasc Biol 2012; 32:1613-1623.
21. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10:427-439.
22. Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Ann Rev Pathol Mech Dis 2014; 9:181-218.
23. Mócsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. The J Exp Med 2013; 210:1283-1299.
24. Rajendran P, Rengarajan TF, Thangavel JF et al. The vascular endothelium and human diseases. 1449-2288 (Electronic).
25. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13:159-175.
26. von Hundelshausen P, Weber KS, Huo Y et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103:1772-1777.
27. Soehnlein Drechsler M, Döring Y et al. Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Molecular Medicine 2013; 5:471-481.
28. Döring Y, Noels H, Mandl M et al. Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: Short Communication. Circulation Res 2014; 114:976-981.
29. Burkhart JM, Vaudel M, Gambaryan S et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012; 120: e73-e82.
30. Hartwig H, Drechsler M, Lievens D et al. Plateletderived PF4 reduces neutrophil apoptosis following arterial occlusion. Thromb Haemost 2014; 111:562-564.
31. Koenen RR, von Hundelshausen P, Nesmelova IV et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009; 15:97-103.
32. Grommes J, Alard JE, Drechsler M et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med 2012; 185:628-636.
33. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9:61-67.
34. Massberg S, Brand K, Grüner S et al. A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation. J Exp Med 2002; 196:887-896.
35. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013; 13:709-721.
36. Drechsler M, Soehnlein O. The Complexity of Arterial Classical Monocyte Recruitment. J Innate Immunity 2013; 5:358-366.
37. Soehnlein O, Xie X, Ulbrich H et al. Neutrophilderived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte Arrest under flow conditions. J Immunol 2005; 174:6399-6405.
38. Taekema-Roelvink Mej, Kooten CV, Kooij SVD et al. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001; 12:932-940.
39. Quinn KL, Henriques M, Tabuchi A et al. Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation. Arterioscler Thromb Vasc Biol 2011; 31:2070-2079.
40. Soehnlein O, Lindbom L, Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 2009; 114:4613-4623.
41. Döring Y, Drechsler M, Wantha S et al. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circulation Res 2012; 110:1052-1056.
42. Wantha S, Alard JE, Megens RTA et al. Neutrophilderived cathelicidin promotes adhesion of classical monocytes. Circulation Res 2013; 112:792-801.
43. Chalaris A, Rabe B, Paliga K et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 2007; 110:1748-1755.
44. Schuett H, Oestreich R, Waetzig GH et al. Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012; 32:281-290.
45. Moore K, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145:341-355.
46. Soehnlein O, Kai-Larsen Y, Frithiof R et al. Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest 2008; 118:3491-3502.
47. Gombart AF, Krug U, O'Kelly J et al. Aberrant expression of neutrophil and macrophage-related genes in a murine model for human neutrophilspecific granule deficiency. J Leukoc Biol 2005; 78:1153-1165.
48. Shiohara M, Gombart AF, Sekiguchi Y et al. Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency. J Leukoc Biol 2004; 75:190-197.
49. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol 2009; 31:35-47.
50. Falk E, Nakano M, Bentzon JF et al. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34:719-728.
51. Silvestre-Roig C, de Winther MP, Weber C et al. Atherosclerotic plaque destabilization: Mechanisms, models, and therapeutic strategies. Circ Res 2014; 114:214-226.
52. Rotzius P, Thams S, Soehnlein O et al. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/-mice. Am J Pathol 2010; 177:493-500.
53. Buffon A, Biasucci LM, Liuzzo G et al. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12.
54. Newby AC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vasc Pharmacol 2012; 56:232-244.
55. Lenglet S, Thomas Al, Soehnlein O et al. Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice. Arterioscler Thromb Vasc Biol 2013; 33:215-223.
56. Laxton RC, Hu Y, Duchene J et al. A role of matrix metalloproteinase-8 in atherosclerosis. Circulation Research 2009; 105:921-929.
57. Quillard T, Araújo HA, Franck G et al. Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata. Arterioscler Thromb Vasc Biol 2014; 34:1179-1186.
58. Quillard T, Tesmenitsky Y, Croce K et al. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31:2464-2472.
59. Van den Steen PE, Wuyts A, Husson SJ et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 2003; 270:3739-3749.
60. Tester AM, Cox JH, Connor AR et al. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2007; 2: e312.
61. Meuwese MC, Stroes ESG, Hazen SL et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 50:159-165.
62. Naruko T, Ueda M, Haze K et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106:2894-2900.
63. Lau D, Mollnau H, Eiserich JP et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005; 102:431-436.
64. Wang JG, Mahmud SA, Nguyen J, Slungaard A. Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: A novel HOSCN-specific oxidant mechanism to amplify inflammation. J Immunol 2006; 177:8714-8722.
65. Norata GD, Marchesi P, Pulakazhi Venu VK et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009; 120:699-708.
66. Ait-Oufella H, Kinugawa K, Zoll J et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 2007; 115:2168-2177.
67. Thorp E, Vaisar T, Subramanian M et al. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase C_, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 2011; 286:33335-33344.
68. Sather SK. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2006; 109:1026-1033.
69. Driscoll WS, Vaisar T, Tang J et al. Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype. Circ Res 2013; 113:52-61.
70. Van den Berg CW, Tambourgi DV, Clark HW et al. Mechanism of neutrophil dysfunction: Neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol 2014; 192:1787-1795.